Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

被引：0
|
作者：
C Stephan
H Jaeger
A Carganico
G Knecht
T Lutz
C Mayr
FA Mosthaf
S Koeppe
M Mueller
E Wolf
A Tappe
E Wellmann
H Knechten
机构：
[1] Klinikum der Johann-Wolfgang-Goethe-Universität,MVZ Karlsplatz
[2] HIV Research and Clinical Care Centre,undefined
[3] Praxis Dres. S. Dupke/A. Carganico/A. Baumgarten,undefined
[4] Infektiologikum Frankfurt,undefined
[5] MVZ-Aerzteforum Seestrasse,undefined
[6] Praxis Dres. F. A. Mosthaf/M. Procaccianti/K. Zutavern-Bechtold,undefined
[7] Praxis Dres. S. Koeppe/P. Kreckel,undefined
[8] Praxis Dres. B. Frietsch/A. Ulmer/M. Mueller,undefined
[9] MUC Research,undefined
[10] Roche Pharma AG,undefined
[11] Praxenzentrum Blondelstrasse (PZB),undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
HIV; protease inhibitor; saquinavir; cholesterol; triglycerides;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Good efficacy but side effects including hypercholesterolemia and body weight gain after switching to dolutegravir plus booster protease inhibitor regimen among treatment experienced HIV-positive patients
    Lee, Y-L
    Liu, C-E
    Hung, C-C
    Lin, K-Y
    Cheng, S-H
    Yang, C-J
    Lee, Y-T
    Lin, S-P
    Wang, N-C
    HIV MEDICINE, 2019, 20 : 63 - 63
  • [22] Do protease inhibitor-containing combination antiretroviral therapy regimens increase risk of spontaneous preterm birth in pregnant HIV-Positive women?
    Pakzad, Z.
    Wagner, E. C.
    Chaworth-Musters, T.
    Berg, K.
    Albert, A. Y. K.
    van Schalkwyk, J.
    Maan, E.
    Azampanah, A.
    McClymont, E.
    Alimenti, A.
    Forbes, J.
    Money, D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (06) : 716 - 716
  • [23] Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy
    Ucciferri, Claudio
    Falasca, Katia
    Vignale, Francesca
    Di Nicola, Marta
    Pizzigallo, Eligio
    Vecchiet, Jacopo
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (05) : 755 - 759
  • [24] Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders
    Wilde, JT
    Lee, CA
    Collins, P
    Giangrande, PLF
    Winter, M
    Shiach, CR
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) : 556 - 559
  • [25] Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen
    Moya, J.
    Casado, J. L.
    Aranzabal, L.
    Moreno, A.
    Antela, A.
    Dronda, F.
    Perez-Elías, M. J.
    Marin, A.
    Moreno, S.
    HIV CLINICAL TRIALS, 2006, 7 (04): : 210 - 214
  • [26] Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV-positive women with highly active antiretroviral therapy-associated massive breast enlargement (vol 16, pg 307, 2002)
    Carsana, L
    AIDS PATIENT CARE AND STDS, 2002, 16 (09) : 465 - 465
  • [27] The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy
    Staszewski, Schlomo
    Babacan, Errol
    Stephan, Christoph
    Haberl, Annette
    Carlebach, Amina
    Gute, Peter
    Klauke, Stephan
    Hermschulte, Yvonne
    Stuermer, Martin
    Dauer, Brenda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 1024 - 1030
  • [28] Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen
    Renaud, M
    Katlama, C
    Mallet, A
    Calvez, V
    Carcelain, G
    Tubiana, R
    Jouan, M
    Caumes, E
    Agut, H
    Bricaire, F
    Debré, P
    Autran, B
    AIDS, 1999, 13 (06) : 669 - 676
  • [29] Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients
    Cooper, Megan
    Dunne, Ian
    Kuten, Samantha
    Curtis, Anna
    Graviss, Edward A.
    Nguyen, Duc T.
    Hobeika, Mark
    Gaber, A. Osama
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 984 - 988
  • [30] Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
    Opravil, M
    Baumann, D
    Chave, JP
    Furrer, H
    Calmy, A
    Bernasconi, E
    Blasko, M
    Vernazza, P
    Ledergerber, B
    Perrin, L
    AIDS, 2004, 18 (16) : 2213 - 2215
12345